Hypersenstivity
Exaggerated immune responses that cause inflammation and tissue damage
The 4 types of hypersensitivity reactions are classified by thier ____
Effector mechanisms
Type 1 Overview
IgE mediated hypersensitivity to harmless antigens (soluble)
Type 2 Overview
Antibody mediated destruction of cells
Type 3 Overview
Immune complex mediated
Type 4 Overview
T cell mediated
Type 1 mechanism
Allergic response to harmless environmental antigen
Sensitization
Initial exposure generates a primary immune response
Allergy
State of hypersensitivity to a non-harmful antigen
Type 1 what happens with a second exposure to the original allergen?
Early phase: immediate
- effector function of IgE-mediated activation of mast cells = degranulation and release of histamine and TNF-alpha, leading to an inflammatory response at the site of allergy exposure
Allergen specific IgE
Mast cells express Fc-receptors for IgE
- found in connective tissues surrounding blood vessels and in the mucosa of the gut and airways
Mast cell degranulation effect on tissues
GIT: increased fluid secretion, increased peristalsis = expulsion of GIT contents
Airways: decreased diameter, increased mucus secretion = expulsion of airway contents
Blood vessels: increased blood flow, increased permeability = edema, inflammation, increased lymph flow and carriage of antigen to lymph nodes
Late phase (6-8 hours)
Mast cell synthesis
What is the goal of the late phase response?
Recruit leukocytes with anti-parasite effector functions (eosinophils and basophils)
- could result in narrowing of airway or sustained edema
Type 1 systemic response
Allergen enters blood stream
- IgE mediated activation of mast cells (CT mast cells associated with blood vessels throughout the body
Anaphylaxis
Immediate type 1 hypersensitive reaction causing circulatory shock and suffocation due to bronchiole constriction
Histamine release by mast cells
Examples of allergens
Heart/vascular system systemic response
Respiratory tract systemic response
GIT systemic response
Type 2 drug-induced hemolytic anemia
Type 2 mechanism
Type 2 second exposure